[Federal Register Volume 77, Number 175 (Monday, September 10, 2012)]
[Notices]
[Page 55504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-22154]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Research Triangle Institute

    By Notice dated May 15, 2012, and published in the Federal Register 
on May 22, 2012, 77 FR 30327, Research Triangle Institute, Hermann 
Building, East Institute Drive, P.O. Box 12194, Research Triangle, 
North Carolina 27709, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Cocaine (9041).............................  II
------------------------------------------------------------------------

    The Institute will manufacture marihuana, and cocaine derivatives 
for use by their customers in analytical kits, reagents, and reference 
standards as directed by the National Institute on Drug Abuse.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Research Triangle Institute to manufacture the listed basic classes 
of controlled substances is consistent with the public interest at this 
time. DEA has investigated Research Triangle Institute to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 
1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-22154 Filed 9-7-12; 8:45 am]
BILLING CODE 4410-09-P